参考文献/References:
[1]Hung MW,Kravtsov GM,Lau CF,et al.Melatonin ameliorates endothelial dysfunction, vascular inflammation, and systemic hypertension in rats with chronic intermittent hypoxia[J].J Pineal Res,2013,55(3):247-256.
[2]Ma CY,Xu ZY, Wang SP,et al.Change of Inflammatory Factors in Patients with Acute Coronary Syndrome[J].Chin Med J (Engl),2018,131(12):1444-1449.
[3]Awad EM,Khan SY,Sokolikova B,et al.Cold induces reactive oxygen species production and activation of the NF-kappa B response in endothelial cells and inflammation in vivo[J].J Thromb Haemost,2013,11(9):1716-1726.
[4]Kong L,Luo C,Li X,et al.The anti-inflammatory effect of kaempferol on early atherosclerosis in high cholesterol fed rabbits[J].Lipids Health Dis,2013(12):115.
[5]Cwikiel J,Seljeflot I,Berge E,et al.Effect of strenuous exercise on mediators of inflammation in patients with coronary artery disease[J].Cytokine, 2018(105):17-22.
[6]Hibbert B,Maze R,Pourdjabbar A,et al.A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study[J].PloS one,2014,9(3):e92078.
[7]Adamski P,Kozinski M,Ostrowska M,et al.Overview of pleiotropic effects of platelet P2Y12 receptor inhibitors[J].Thromb Haemost,2014,112(2):224-242.
[8]Lindholm D,Varenhorst C,Cannon CP,et al.Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization:results from the PLATO trial[J].Eur Heart J,2014:2083-2093.
[9]Serebruany VL.Adenosine release: a potential explanation for the benefits of ticagrelor in the PLATelet inhibition and clinical outcomes trial[J].Am Heart J,2011,161(1):1-4.
[10]Kubisa MJ,Jezewski MP,Gasecka A,et al.Ticagrelor toward more efficient platelet inhibition and beyond[J].Ther Clin Risk Manag,2018(14):129-140.
相似文献/References:
[1]张 毅.替格瑞洛对不稳定型心绞痛患者PCI术后缺血事件及炎症因子水平的影响[J].医学信息,2022,35(13):130.[doi:10.3969/j.issn.1006-1959.2022.13.030]
ZHANG Yi.Effect of Ticagrelor on Ischemic Events and Inflammatory Factors in Patients with Unstable Angina Pectoris After PCI[J].Journal of Medical Information,2022,35(22):130.[doi:10.3969/j.issn.1006-1959.2022.13.030]
[2]王 焕.替格瑞洛在氯吡格雷抵抗AMI患者PCI术后抗血小板治疗中的应用[J].医学信息,2019,32(24):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
WANG Huan.Application of Ticagrelor in the Antiplatelet Therapy of Clopidogrel in Patients with AMI after PCI[J].Journal of Medical Information,2019,32(22):153.[doi:10.3969/j.issn.1006-1959.2019.24.055]
[3]吴浩瑜.院前急救中应用不同抗血小板药物组合对ST段抬高型急性心肌梗死患者近期心血管事件的影响[J].医学信息,2021,34(22):57.[doi:10.3969/j.issn.1006-1959.2021.22.016]
WU Hao-yu.Effects of Different Antiplatelet Drug Combinations in Pre-hospital Emergency Treatment on Recent Cardiovascular Events in Patients with ST-segment Elevation Acute Myocardial Infarction[J].Journal of Medical Information,2021,34(22):57.[doi:10.3969/j.issn.1006-1959.2021.22.016]
[4]程 林.替格瑞洛对冠心病患者PCI治疗术后冠脉微循环功能的影响[J].医学信息,2020,33(07):156.[doi:10.3969/j.issn.1006-1959.2020.07.051]
CHENG Lin.Effect of Ticagrelor on Coronary Microcirculation Function in Patients with Coronary Heart Disease After PCI Treatment[J].Journal of Medical Information,2020,33(22):156.[doi:10.3969/j.issn.1006-1959.2020.07.051]
[5]程 林.低剂量替格瑞洛治疗稳定型冠心病患者的疗效及安全性评价[J].医学信息,2020,33(08):161.[doi:10.3969/j.issn.1006-1959.2020.08.053]
CHENG Lin.Efficacy and Safety of Low-dose Ticagrelor in the Treatment of Stable Coronary Heart Disease[J].Journal of Medical Information,2020,33(22):161.[doi:10.3969/j.issn.1006-1959.2020.08.053]
[6]张 蕊,耿 佳,王雪梅.长链非编码RNA在内皮细胞损伤模型中的表达调控研究[J].医学信息,2020,33(22):71.[doi:10.3969/j.issn.1006-1959.2020.22.022]
ZHANG Rui,GENG Jia,WANG Xue-mei.Study on the Expression Regulation of Long Non-coding RNA in Endothelial Cell Injury Model[J].Journal of Medical Information,2020,33(22):71.[doi:10.3969/j.issn.1006-1959.2020.22.022]